Feature iBio spearheading plant-based biopharmaceuticals at CDMO plant By Len Zehr iBio (NYSE American:IBIO) has developed an industry-leading plant-based gene-expression technology to rapidly produce high levels of proteins used for making biologics at its contract development and... December 18, 2018